Growth Metrics

Invivyd (IVVD) Change in Accured Expenses (2021 - 2025)

Invivyd posted quarterly Change in Accured Expenses of -$6.0 million for Q4 2025, up 62.49% year-on-year from -$3.7 million in Q4 2024, and up 75.77% on a QoQ basis from -$24.8 million in Q3 2025.

Invivyd (IVVD) has 5 years of Change in Accured Expenses data on file, last reported at -$6.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 62.49% year-over-year to -$6.0 million; the trailing twelve-month figure through Dec 2025 stood at -$30.8 million (down 385487.5% YoY), and the FY2025 full-year result was -$30.8 million, down 385487.5% from the prior year.
  • Change in Accured Expenses for Q4 2025 stood at -$6.0 million, up from -$24.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $20.3 million in Q1 2022 and bottomed at -$30.1 million in Q4 2021.
  • The 5-year median for Change in Accured Expenses is -$3.0 million (2023), against an average of -$3.3 million.
  • Peak annual rise in Change in Accured Expenses reached 248.77% in 2024, while the deepest fall reached 53669.23% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$30.1 million in 2021, then soared by 75.72% to -$7.3 million in 2022, then soared by 174.42% to $5.4 million in 2023, then tumbled by 394.74% to -$16.0 million in 2024, then surged by 62.49% to -$6.0 million in 2025.
  • The last three Change in Accured Expenses figures came in at -$6.0 million (Q4 2025), -$24.8 million (Q3 2025), and $10.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 931,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 70.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -176.03 Mn
10 Invivyd 208.38 Mn -18.31 Mn - -6.02 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -6.02 Mn
Dec 31, 2025 -6.02 Mn
Sep 30, 2025 -24.83 Mn
Sep 30, 2025 -24.83 Mn
Jun 30, 2025 10.01 Mn
Jun 30, 2025 10.01 Mn
Mar 31, 2025 -10.01 Mn
Mar 31, 2025 -10.01 Mn
Dec 31, 2024 -16.04 Mn
Dec 31, 2024 -16.04 Mn
Sep 30, 2024 16.05 Mn
Sep 30, 2024 16.05 Mn
Jun 30, 2024 6.95 Mn
Jun 30, 2024 6.95 Mn
Mar 31, 2024 -6.96 Mn
Mar 31, 2024 -6.96 Mn
Dec 31, 2023 5.44 Mn
Dec 31, 2023 5.44 Mn
Sep 30, 2023 -10.79 Mn
Sep 30, 2023 -10.79 Mn
Jun 30, 2023 5.32 Mn
Jun 30, 2023 5.32 Mn
Mar 31, 2023 13,000.00
Mar 31, 2023 13,000.00
Dec 31, 2022 -7.31 Mn
Dec 31, 2022 -7.31 Mn
Sep 30, 2022 -27.61 Mn
Sep 30, 2022 -27.61 Mn
Jun 30, 2022 -20.20 Mn
Jun 30, 2022 -20.20 Mn
Mar 31, 2022 20.26 Mn
Mar 31, 2022 20.26 Mn
Dec 31, 2021 -30.12 Mn
Dec 31, 2021 -30.12 Mn
Sep 30, 2021 9.07 Mn
Sep 30, 2021 9.07 Mn
Jun 30, 2021 8.67 Mn
Jun 30, 2021 8.67 Mn
Mar 31, 2021 12.39 Mn
Mar 31, 2021 12.39 Mn